Literature DB >> 1288421

Biochemical responses of skin to allergenic and non-allergenic nitrohalobenzenes. Evidence that an NADPH-dependent reductase in skin may act as a prohapten-activating enzyme.

R J Schmidt1, L Y Chung.   

Abstract

Using a selection of 'classic' haptens (dinitrohalobenzenes and picryl chloride) and related non-sensitizing analogous, we examined changes in levels of glutathione (GSH) and glutathione disulphide (GSSG) in mouse skin 12 h after their epicutaneous application. We observed that elevation of GSSG levels and/or depletion of GSH levels correlated well with contact allergenic potential. Non-sensitizing analogous failed to perturb GSH/GSSG status. In vitro assays using mouse skin and rat liver microsomal preparations indicated that only the allergenic nitrohalobenzenes initiated NADPH-dependent oxygen utilization, with the activity falling off in the order picryl chloride >> DNIB > DNBB > DNCB > DNFB. In addition, an examination of the colour of mouse skin homogenates ex vivo after application of the dinitrohalobenzenes showed significant yellowing (consistent with aromatic nucleophilic substitution) only with DNFB. Our results indicate that, while an aromatic nucleophilic substitution reaction with skin protein can possibly account for the allergenicity of DNFB, it does not seem to occur with DNCB, DNBB or DNIB. These may instead behave mainly as prohaptens which are activated enzymically by NADPH-dependent reductase(s) within the skin, with the concomitant generation of superoxide and hydrogen peroxide, to form potentially protein-reactive free radical and other metabolites. Picryl chloride appears capable of both conjugating directly with proteins by aromatic nucleophilic substitution and undergoing NADPH-dependent metabolism to other potentially protein-reactive metabolites.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1288421     DOI: 10.1007/bf00372070

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  21 in total

Review 1.  Novel pathways in drug metabolism.

Authors:  P Jenner; B Testa
Journal:  Xenobiotica       Date:  1978-01       Impact factor: 1.908

2.  The effect of physical and chemical properties of the sensitizing substance on the induction and elicitation of delayed contact sensitivity.

Authors:  H P Godfrey; H Baer
Journal:  J Immunol       Date:  1971-02       Impact factor: 5.422

3.  Effect of nitrobenzene derivatives on electron transfer in cellular and chemical models.

Authors:  J E Biaglow; B Jacobson
Journal:  Mol Pharmacol       Date:  1977-03       Impact factor: 4.436

Review 4.  Glutathione depletion and susceptibility.

Authors:  D J Reed; M W Fariss
Journal:  Pharmacol Rev       Date:  1984-06       Impact factor: 25.468

5.  Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine.

Authors:  O W Griffith
Journal:  Anal Biochem       Date:  1980-07-15       Impact factor: 3.365

6.  Epidermis: a site of drug metabolism in neonatal rat skin. Studies on cytochrome P-450 content and mixed-function oxidase and epoxide hydrolase activity.

Authors:  D R Bickers; T Dutta-Choudhury; H Mukhtar
Journal:  Mol Pharmacol       Date:  1982-01       Impact factor: 4.436

7.  The role of catalytic superoxide formation in the O2 inhibition of nitroreductase.

Authors:  R P Mason; J L Holtzman
Journal:  Biochem Biophys Res Commun       Date:  1975-12-15       Impact factor: 3.575

8.  Mechanism for the several activities of the glutathione S-transferases.

Authors:  J H Keen; W H Habig; W B Jakoby
Journal:  J Biol Chem       Date:  1976-10-25       Impact factor: 5.157

9.  Extent of cutaneous metabolism during percutaneous absorption of xenobiotics.

Authors:  R L Bronaugh; R F Stewart; J E Storm
Journal:  Toxicol Appl Pharmacol       Date:  1989-07       Impact factor: 4.219

10.  STUDIES ON THE SENSITIZATION OF ANIMALS WITH SIMPLE CHEMICAL COMPOUNDS. II.

Authors:  K Landsteiner; J Jacobs
Journal:  J Exp Med       Date:  1936-09-30       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.